The Brazil therapeutic respiratory devices market size is expected to reach USD 502.7 million by 2030, exhibiting a CAGR of 6.5% during the forecast period, according to this report. Growing geriatric population, and increasing prevalence of respiratory diseases are the key factors that are driving the growth. Moreover, the market is expected to grow owing to rapid technological advancements in the healthcare sector. Furthermore, respiratory monitoring devices use software applications for the collection and analysis of data from ventilators equipped with the health system.
The availability of ventilators during the COVID-19 pandemic has significantly improved operational capabilities. Organizations like the American Association for Respiratory Care collaborated to train respiratory therapists in ventilator operation, thereby boosting market players to increase production capacity. For example, Royal Philips aimed to double hospital ventilator production by May 2020 and achieve a four-fold growth by Q3 2020.
The growing prevalence of respiratory diseases is a major growth driver for this market. According to the World Health Organization (WHO), COPD caused 3.23 million deaths in 2019, making it the third leading cause of death globally. Additionally, WHO projects that by 2030, lung cancer, tuberculosis, COPD, and pneumonia will account for approximately one in five deaths worldwide, up from one-sixth of all deaths in 2008.
The market is expected to witness intense competition due to the influx of numerous startups seeking opportunities in this sector. For instance, Magnamed, a startup based in São Paulo, announced in April 2020 that it would collaborate with leading Brazilian and multinational corporations to produce 6,500 ventilators by August 2020. This initiative, supported by FAPESP, addresses the urgent need for respiratory devices in treating COVID-19 patients. The growing support for such startup initiatives is anticipated to foster competition within the market, driving innovation and advancements in respiratory care.
The availability of ventilators during the COVID-19 pandemic has significantly improved operational capabilities. Organizations like the American Association for Respiratory Care collaborated to train respiratory therapists in ventilator operation, thereby boosting market players to increase production capacity. For example, Royal Philips aimed to double hospital ventilator production by May 2020 and achieve a four-fold growth by Q3 2020.
The growing prevalence of respiratory diseases is a major growth driver for this market. According to the World Health Organization (WHO), COPD caused 3.23 million deaths in 2019, making it the third leading cause of death globally. Additionally, WHO projects that by 2030, lung cancer, tuberculosis, COPD, and pneumonia will account for approximately one in five deaths worldwide, up from one-sixth of all deaths in 2008.
The market is expected to witness intense competition due to the influx of numerous startups seeking opportunities in this sector. For instance, Magnamed, a startup based in São Paulo, announced in April 2020 that it would collaborate with leading Brazilian and multinational corporations to produce 6,500 ventilators by August 2020. This initiative, supported by FAPESP, addresses the urgent need for respiratory devices in treating COVID-19 patients. The growing support for such startup initiatives is anticipated to foster competition within the market, driving innovation and advancements in respiratory care.
Brazil Therapeutic Respiratory Devices Market Report Highlights
- In 2022, the oxygen concentrator segment held the third leading position in the market. Factors such as increasing demand for home oxygen therapy, technological advancements in respiratory devices, rising incidence of respiratory diseases, rapid growth in the aging population, and high tobacco consumption contribute to the growth of this segment
- The HEPA filter segment accounted for second dominated the market position in 2022 and accounted for a revenue share of 35.06%. The prevalence of respiratory diseases and their transmission are among the factors driving the demand for HEPA filters
- The ventilator filters segment is anticipated to dominate the segment over the forecast period. An increase in the prevalence of respiratory disorders is anticipated to have a substantial influence on the market. Consequently, this creates opportunities for the ventilator filters market
- Major key players implement strategies such as mergers, acquisitions, strategic partnerships, product launches, or collaborations with local players to expand their market share
- Some of the notable players are Koninklijke Philips NV; Medtronic; Masimo; Chart Industries; Hamilton Medical; BD (Becton, Dickinson and Company); ResMed Inc.; General Electric Company (GE HealthCare); Drägerwerk AG & Co. KGaA; and Fisher & Paykel Healthcare Limited
Table of Contents
Chapter 1 Report Scope and Objectives
Chapter 2 Methodology
Chapter 3 Executive Summary
Chapter 4 Market Variables, Trends & Scope
Chapter 5 Brazil Therapeutic Respiratory Devices Market: Product Analysis
Chapter 6 Brazil Therapeutic Respiratory Devices Market: Technology TypeAnalysis
Chapter 7 Brazil Therapeutic Respiratory Devices Market: Filters Analysis
List of Tables
List of Figures
Companies Mentioned
- Koninklijke Philips NV
- Medtronic
- Masimo
- Chart Industries
- Hamilton Medical
- BD (Becton, Dickinson and Company)
- ResMed Inc.
- General Electric Company (GE HealthCare)
- Drägerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare Limited
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 100 |
Published | June 2023 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 302.4 Million |
Forecasted Market Value ( USD | $ 502.7 Million |
Compound Annual Growth Rate | 6.5% |
Regions Covered | Brazil |
No. of Companies Mentioned | 10 |